platinum derivatives pharmaceutical formulations

The present invention is directed to novel stable formulations of oxaliplatin, in which the lactic acid and / or a pharmaceutically acceptable salt serves as a novel means for preparing a dosage unit with an improved stability. Also within the scope of this invention a method for manufacturing such formulations ready for administration and their use in tumor therapy.